About this blog
In July 2017 I decided to start following as many of the top infectious disease journals as I could, curating the most interesting and important papers from each journal and sharing them with the other infectious disease fellows in my program. One year and more than 8000 articles later, my colleagues encouraged me to share these literature reviews with a wider audience, and this blog was born.
How it works:
Several times each month I gather abstracts to review using a PubMed search that includes 30 ID-related keywords, including both generic and specific terms (e.g. “infection,” “antibiotic,” “fungus” as well as “bacteremia,” “beta-lactam,” and “tuberculosis”). I limit the search by publication date, including only the month in question, as well as to a select group of journals. Currently, I review from the following 30 journals:
New England Journal of Medicine
Journal of the American Medical Association
JAMA Internal Medicine
Annals of Internal Medicine
Lancet Infectious Diseases
Clinical Infectious Diseases
Journal of Infectious Diseases
Open Forum Infectious Diseases
Clinical Microbiology and Infection
European Journal of Clinical Microbiology & Infectious Diseases
Journal of Infection
International Journal of Infectious Diseases
BMC infectious diseases
Infection Control and Hospital Epidemiology
American Journal of Tropical Medicine and Hygiene
Emerging Infectious Diseases
Emerging microbes & infections
American Journal of Transplantation
AIDS patient care and STDs
Journal of Acquired Immune Deficiency Syndromes
Journal of the International AIDS Society
Sexually transmitted diseases
Journal of Antimicrobial Chemotherapy
Antimicrobial Agents and Chemotherapy
International Journal of Antimicrobial Agents
These searches produce about 1200 articles each month. From the titles, I select 200-300 abstracts to read in full, and from these I choose 20-30 papers to review. I try to select papers that have the potential to inform and change the clinical practice of infectious diseases, that generate important new hypotheses about infections or challenge old ones, or that will be of wide interest to infectious disease practitioners for other reasons. Finally, I group each month's papers by area of interest (e.g. antimicrobial agents, HIV ID, infection control) and publish them in a series of monthly blog posts.
I do my best to point out when I have a personal relationship (e.g. mentor, former co-fellow) with any of an article’s co-authors. I have not and do not plan to include any of my own publications in these reviews.
I have no financial conflicts of interest relevant to the topics discussed on this website; specifically, I do not own stock in or receive funding from any pharmaceutical company or healthcare organization for this work.
The views and opinions on this website are my own and not those of Baylor College of Medicine, CHI St. Luke’s Health, the Harris Health System, the Department of Veteran’s Affairs, the MD Anderson Cancer Center, or any other organization with which I am employed or affiliated. Nothing on this blog should be construed as medical advice or a substitute for consultation with an infectious disease specialist.
About the author - Nicolás Cortés-Penfield, MD
I am a fellow in infectious diseases participating in the ABIM clinical-investigator research pathway at the Baylor College of Medicine. I completed the bulk of my clinical training in 2017 and currently investigate human norovirus infection under the mentorship of Dr. Mary Estes. My primary interests within ID are enteric viral infections, vaccines, HIV care, and antimicrobial stewardship; my other interests include medical ethics and medical education. After fellowship, I plan to continue my career in academic infectious diseases. I live in Houston with my wife Lydia and daughter Elise. We have a cat, Tigrette, who my wife insisted I not name Zosyn.